The Challenge of Cancer Pain Assessment.

Ulster Med J · 2018 · PMC6169411 · PMID 30559542

Europe PMC

hedged sentence

—

closest p

—

boldest claim

The sentences

hugely significantno p-value reported

Despite vast advances in both the diagnosis and treatment of cancer in recent years, alongside hugely significant pharmacological and technological developments, 52-77% of cancer patients experience pain 1 and 35% of these patients report their pain as being moderate to severe 2 .

also in 172 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.